- Home
- MBBC vs TENX Comparison
MBBC vs TENX Comparison
Compare MBBC & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBBC
- TENX
- Stock Information
- Founded
- MBBC 1902
- TENX 1967
- Country
- MBBC United States
- TENX United States
- Employees
- MBBC N/A
- TENX N/A
- Industry
- MBBC Banks
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- MBBC Finance
- TENX Health Care
- Exchange
- MBBC Nasdaq
- TENX Nasdaq
- Market Cap
- MBBC 22.1M
- TENX 21.6M
- IPO Year
- MBBC N/A
- TENX N/A
- Fundamental
- Price
- MBBC $10.01
- TENX $6.07
- Analyst Decision
- MBBC
- TENX Strong Buy
- Analyst Count
- MBBC 0
- TENX 3
- Target Price
- MBBC N/A
- TENX $16.00
- AVG Volume (30 Days)
- MBBC 10.5K
- TENX 9.7K
- Earning Date
- MBBC 05-14-2025
- TENX 05-14-2025
- Dividend Yield
- MBBC N/A
- TENX N/A
- EPS Growth
- MBBC 103.56
- TENX N/A
- EPS
- MBBC 0.22
- TENX N/A
- Revenue
- MBBC $6,591,743.00
- TENX N/A
- Revenue This Year
- MBBC N/A
- TENX N/A
- Revenue Next Year
- MBBC N/A
- TENX N/A
- P/E Ratio
- MBBC $45.44
- TENX N/A
- Revenue Growth
- MBBC N/A
- TENX N/A
- 52 Week Low
- MBBC $5.83
- TENX $2.77
- 52 Week High
- MBBC $12.00
- TENX $7.89
- Technical
- Relative Strength Index (RSI)
- MBBC N/A
- TENX 58.47
- Support Level
- MBBC N/A
- TENX $6.00
- Resistance Level
- MBBC N/A
- TENX $6.23
- Average True Range (ATR)
- MBBC 0.00
- TENX 0.24
- MACD
- MBBC 0.00
- TENX 0.04
- Stochastic Oscillator
- MBBC 0.00
- TENX 71.35
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.